Index Catalog // Hyrax

Remover filtros

Filtragem por: Contributor Hu, Mengjie Platform Presentation No thank you

Descrição:: Background BRAF mutations are common in melanoma, with more than 50% harboring activating BRAF mutations. Though BRAF inhibitors are highly efficacious for nearly half of patients with this BRAF-mutant melanoma, many developing secondary resistance...
Data Criada:: August 1-2, 2024

Filtre sua busca